iBio (IBIO) Change in Inventory (2016 - 2023)
iBio (IBIO) posted quarterly Change in Inventory of -$43000.0 for Q1 2023, down 103.31% year-over-year from $1.3 million in Q1 2022, and up 45.57% quarter-over-quarter from -$79000.0 in Q4 2022.
iBio (IBIO) Change in Inventory (2016 - 2023) Analysis & Trends
iBio (IBIO) has reported Change in Inventory for 6 consecutive years, with -$43000.0 the latest figure, recorded in Q1 2023.
- In Q1 2023, Change in Inventory fell 103.31% year-over-year to -$43000.0; the TTM figure through Jun 2023 stood at $1.0 million (down 73.79% YoY), while the FY2023 annual figure was $1.0 million, down 73.79% from the prior year.
- Change in Inventory climbed to -$43000.0 in Q1 2023 per IBIO's latest filing, from -$79000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $1.4 million in Q4 2021 and bottomed at -$639000.0 in Q1 2021.
- Historically, Change in Inventory has averaged $374181.8 across 4 years, with a median of $228000.0 in 2020.
- Annual changes were most pronounced in 2021 — Change in Inventory jumped 1144.44% — and 2022, when it sank 105.65%.
- iBio's Change in Inventory stood at $228000.0 in 2020, then soared by 513.6% to $1.4 million in 2021, then sank by 105.65% to -$79000.0 in 2022, then soared by 45.57% to -$43000.0 in 2023.
- Business Quant data shows IBIO's Change in Inventory at -$43000.0 in Q1 2023, -$79000.0 in Q4 2022, and $1.1 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -43,000.00 |
| Mar 31, 2023 | -43,000.00 |
| Dec 31, 2022 | -79,000.00 |
| Dec 31, 2022 | -79,000.00 |
| Sep 30, 2022 | 1.14 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 616,000.00 |
| Jun 30, 2022 | 616,000.00 |
| Mar 31, 2022 | 1.30 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 560,000.00 |
| Sep 30, 2021 | 560,000.00 |
| Jun 30, 2021 | -406,000.00 |
| Jun 30, 2021 | -406,000.00 |
| Mar 31, 2021 | -639,000.00 |
| Mar 31, 2021 | -639,000.00 |
| Dec 31, 2020 | 228,000.00 |
| Dec 31, 2020 | 228,000.00 |